Anogenital Warts Clinical Trial
Official title:
Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts
An exploratory open label, single treatment trial of anogenital warts with Picato® repeated up to 2 times with two weeks intervals.
The purpose of the present trial is to explore the safety, tolerability and efficacy when treating GW with Picato® 0.05% gel. The primary outcome measures will be related to safety and tolerability and consists of severity of any local reactions in the treated area; treatment-related adverse events (AEs) and serious AEs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02015260 -
A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
|
Phase 2 | |
| Completed |
NCT05156541 -
Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts
|
Phase 3 | |
| Completed |
NCT01532102 -
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
|
Phase 1/Phase 2 | |
| Completed |
NCT02276521 -
Evaluation of Long Term Immunity Following HPV Vaccination
|
Phase 2/Phase 3 | |
| Completed |
NCT01490008 -
Systemic Exposure of Catechins From Veregen 15% Ointment in Patients With External Anogenital Warts and From Oral Intake of Green Tea Beverage in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01387412 -
The Role of Genital Warts in HIV Acquisition in Peru
|
N/A |